Literature DB >> 31538608

Vitamin B12 Deficiency: A Rare Cause of Excessive Daytime Sleepiness.

Imran Khawaja1, Kevin Yingling2, Hazim Bukamur1, Waiel Abusnina2.   

Abstract

None: Excessive daytime sleepiness (EDS) is one of the leading reasons that patients present to sleep clinics. Approximately 10% to 14% of the adults report that excessive sleepiness interferes with their daily lives. Common causes of EDS include obstructive sleep apnea, sleep deprivation, circadian rhythm disorders, medication effects, psychiatric conditions especially depression, and primary hypersomnia such as narcolepsy or central idiopathic hypersomnia. Vitamin B12 deficiency is a rare cause of EDS. We are presenting a case of severe vitamin B12 deficiency as an unusual and rare cause of hypersomnia. CITATION: Khawaja I, Yingling K, Bukamur H, Abusnina W. Vitamin B12 deficiency: a rare cause of excessive daytime sleepiness. J Clin Sleep Med. 2019;15(9):1365-1367.
© 2019 American Academy of Sleep Medicine.

Entities:  

Keywords:  excessive daytime sleepiness; excessive sleepiness; hypersomnia; obstructive sleep apnea; sleep disorders; vitamin B12 deficiency

Year:  2019        PMID: 31538608      PMCID: PMC6760402          DOI: 10.5664/jcsm.7936

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  15 in total

Review 1.  Risk factors for obstructive sleep apnea in adults.

Authors:  Terry Young; James Skatrud; Paul E Peppard
Journal:  JAMA       Date:  2004-04-28       Impact factor: 56.272

Review 2.  Obstructive sleep apnea.

Authors:  Sean M Caples; Apoor S Gami; Virend K Somers
Journal:  Ann Intern Med       Date:  2005-02-01       Impact factor: 25.391

Review 3.  Clinical practice. Vitamin B12 deficiency.

Authors:  Sally P Stabler
Journal:  N Engl J Med       Date:  2013-01-10       Impact factor: 91.245

4.  Subjective daytime sleepiness: dimensions and correlates in the general population.

Authors:  Hyon Kim; Terry Young
Journal:  Sleep       Date:  2005-05       Impact factor: 5.849

5.  Indications for positive airway pressure treatment of adult obstructive sleep apnea patients: a consensus statement.

Authors:  D I Loube; P C Gay; K P Strohl; A I Pack; D P White; N A Collop
Journal:  Chest       Date:  1999-03       Impact factor: 9.410

6.  Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis.

Authors:  J Lindenbaum; E B Healton; D G Savage; J C Brust; T J Garrett; E R Podell; P D Marcell; S P Stabler; R H Allen
Journal:  N Engl J Med       Date:  1988-06-30       Impact factor: 91.245

7.  Excessive daytime sleepiness.

Authors:  J F Pagel
Journal:  Am Fam Physician       Date:  2009-03-01       Impact factor: 3.292

8.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

9.  Predictors of improvements in daytime function outcomes with CPAP therapy.

Authors:  R N Kingshott; M Vennelle; C J Hoy; H M Engleman; I J Deary; N J Douglas
Journal:  Am J Respir Crit Care Med       Date:  2000-03       Impact factor: 21.405

10.  Effects of vitamin B12 on plasma melatonin rhythm in humans: increased light sensitivity phase-advances the circadian clock?

Authors:  K Honma; M Kohsaka; N Fukuda; N Morita; S Honma
Journal:  Experientia       Date:  1992-08-15
View more
  3 in total

1.  Associations between nutritional factors and excessive daytime sleepiness in older patients with chronic kidney disease.

Authors:  Cihan Heybeli; Pinar Soysal; Mehmet Asi Oktan; Lee Smith; Ali Çelik; Rumeyza Kazancioglu
Journal:  Aging Clin Exp Res       Date:  2021-08-27       Impact factor: 3.636

2.  The independent association between vitamin B12 and insomnia in Chinese patients with type 2 diabetes mellitus: a cross-sectional study.

Authors:  Shuyuan Xiong; Zhiping Liu; Ning Yao; Xiaoru Zhang; Qian Ge
Journal:  Nutr Diabetes       Date:  2022-01-17       Impact factor: 4.725

3.  Parp mutations protect from mitochondrial toxicity in Alzheimer's disease.

Authors:  Yizhou Yu; Giorgio Fedele; Ivana Celardo; Samantha H Y Loh; L Miguel Martins
Journal:  Cell Death Dis       Date:  2021-06-25       Impact factor: 8.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.